Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...

Eli Lilly (LLY) reports Q4 earnings Thursday. LLY stock up 8.22% YTD. Chart shows strong bullish momentum with potential for ...

Jefferies analyst Akash Tewari maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on February 3 and set a price target of ...

Erste Group analysts upgraded Eli Lilly stock from Hold to Buy, citing a robust product demand and a promising pipeline of potential successes. The analysts highlighted the pharmaceutical company's ...

Truist Securities reaffirmed its Buy rating and $1,038.00 price target for Eli Lilly and Company (NYSE:LLY) shares, with analyst targets ranging from $580 to $1,190. The company, which has ...

Eli Lilly (LLY) is set to announce Q4 earnings results, with analysts expecting positive growth driven by key drugs and new product launches.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

* EPS estimates are Normalized unless otherwise noted.

Leverage these to understand future stock performance and identify high ... on Thursday, Amazon.com, Eli Lilly, Bristol-Myers Squibb, Honeywell, and ConocoPhillips; and on Friday, Fortive, Kimco ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Lions Gate Entertainment Corp. Cl A 3.38% $1.77B ...

AT&T Inc. Dep. Pfd. (Rep. 1/1000th 4.75% Pfd. Series C) 0.78% AT&T Inc. Dep. Pfd. (Rep. 1/1000th 5% Perp. Pfd. Series A) 0.39% ...